CDC Meeting Notice and Request for Comment on Immunization Practices

Regs.gov: Centers for Disease Control and Prevention

Detected March 14th, 2026

Summary

The CDC has issued a notice for a meeting of the Advisory Committee on Immunization Practices (ACIP) to be held on March 18-19, 2026. The notice also includes a request for written comments, which were due by March 12, 2026. The meeting agenda includes discussions on COVID-19 vaccine injuries and Long-COVID.

View original document View source feed page

What changed

The Centers for Disease Control and Prevention (CDC) has announced a meeting of the Advisory Committee on Immunization Practices (ACIP) scheduled for March 18-19, 2026. This notice also served as a request for public comment on matters including COVID-19 vaccine injuries and Long-COVID, with written comments due by March 12, 2026. The ACIP advises the CDC Director on immunization practices and is mandated to review and revise vaccine schedules for the Vaccines for Children program.

While the comment period has closed, compliance officers should note the topics discussed at the ACIP meeting, as recommendations adopted by the Director of the CDC generally must be covered by applicable health plans. The meeting will be webcast, and further information can be found on the ACIP website. No specific actions are required at this time, as the comment period has passed.

Source document (simplified)

Content

ACTION:

Notice of meeting and request for comment.

SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Committee on Immunization Practices (ACIP). Time will be available for public comment.

DATES:

The meeting will be held on March 18, 2026, from 8 a.m. to 5 p.m., EST, and March 19, 2025, from 8 a.m. to 5 p.m., EST, (times
subject to change; see the ACIP website for updates: https://www.cdc.gov/vaccines/acip/index.html). The meeting is expected to be held at the Centers for Disease Control and Prevention, with virtual option. Written comments
must be received between March 2—12, 2026.

ADDRESSES:

You may submit comments, identified by Docket No. CDC-2026-0199, by either of the methods listed below. CDC does not accept
comments by email.

• Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments.

• Mail: ACIP Secretariat, ACIP Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21-12, Atlanta,
Georgia 30329-4027. Attn: Docket No. CDC-2026-0199.

Instructions: All submissions received must include the Agency name and docket number. For access to the docket to read background documents
or comments received, go to https://www.regulations.gov.

The meeting will be webcast live via the World Wide Web. The webcast link can be found on the ACIP website at https://www.cdc.gov/acip.

FOR FURTHER INFORMATION CONTACT:

ACIP Secretariat, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, Mailstop H21-12, Atlanta, Georgia 30329-4027. Email: ACIP@cdc.gov.

SUPPLEMENTARY INFORMATION:

Purpose: The Advisory Committee on Immunization Practices is charged with advising the Director, Centers for Disease Control and Prevention
(CDC), on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically
review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines
for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines.
Further, under applicable provisions of the Affordable Care Act and section 2713 of the Public Health Service Act, immunization
recommendations of ACIP that have been adopted by the Director, CDC, and appear on CDC immunization schedules generally must
be covered by applicable health plans.

Matters to be Considered: The agenda will include updates on ACIP Workgroups and discussions on COVID-19 vaccine injuries and Long-COVID and ACIP recommendation

  methodology. Recommendation votes may be scheduled for COVID-19 vaccine injuries and Long-COVID and ACIP recommendation methodology.
  Agenda items are subject to change as priorities dictate. For more information on the meeting agenda, visit *https://www.cdc.gov/acip/meetings/index.html.*

Meeting Information: The meeting will be webcast live via the World Wide Web. For more information on ACIP, please visit the ACIP website: https://www.cdc.gov/acip.

Public Participation

Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please
note that comments received, including attachments and other supporting materials, are part of the public record and are subject
to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate
for public disclosure. If you include your name, contact information, or other information that identifies you in the body
of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or
withhold, submissions containing private or proprietary information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near-duplicate examples of a mass-mail campaign. CDC will carefully consider all comments
submitted into the docket.

Written Public Comment: The docket will be opened to receive written comments March 2-12, 2026. Written comments must be received by March 12, 2026.

Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any
scheduled votes, including all votes relevant to the ACIP's Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures
below.

Procedure for Oral Public Comment: All persons interested in making an oral public comment at the March 18—19, 2026, ACIP meeting must submit a request at https://www.cdc.gov/acip/meetings/index.html between March 2—12, 2026, and no later than 11:59 p.m., EST, March 12, 2026, according to the instructions provided.

If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC
will conduct a random draw to determine the speakers for the scheduled public comment session. CDC staff will notify individuals
regarding their request to speak by email by March 16, 2026. To accommodate the significant interest in participation in the
oral public comment session of ACIP meetings, each speaker will be limited to three minutes, and each speaker may speak only
once per meeting.

The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control
and Prevention, has been delegated the authority to sign
Federal Register
notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and
Prevention. [FR Doc. 2026-03877 Filed 2-25-26; 8:45 am] BILLING CODE 4163-18-P